Institutional ticker directory tracking stock mentions, long/short ideas, and high-conviction pitches extracted from quarterly hedge fund letters.
| Ticker | Company | Sector | Industry | Pitches | Stance |
|---|---|---|---|---|---|
| Fund / Manager | Thesis Excerpt | Stance | Period / Date | Action |
|---|---|---|---|---|
Summers Value Fund Andrew Summers | “Zimvie underperformed due to false acquisition rumors and execution struggles post-spin-off, but remains cheap at 1x EV/Sales. The successful divestiture of its Spine segment repaired the balance sheet, supporting a valuation target over $20 per share through internal turnaround or buyout.” | BULL | Q4 2024 Jan 1, 2025 | View Pitch |
Ariel Focus Fund Ariel Investments, LLC | “ZimVie performed well due to better-than-expected quarterly results, raised full-year guidance, and the announced sale of its Spine business. Management plans to use transaction proceeds to reduce debt and improve margins. The manager believes this divestiture transforms ZimVie into a pure-play dental business focused on higher-growth markets.” | BULL | Q4 2023 Dec 31, 2023 | View Pitch |
Each excerpt above is the manager's commentary on this ticker specifically. The full letter has the rest of their portfolio thinking, risk discussion, and broader institutional context.
